Shanxi Shuangyan Health Industry (Group) Co., LtdShanxi Shuangyan Health Industry (Group) Co., Ltd

International Biosynthetic Enterprise

Products

R&D and Innovation

Market Coverage Range

The global sales network covers more than 50 countries.

Mainly distributed in Europe, the United States, the Middle East, Africa and Southeast Asia, etc.

Medicine Catalog »

Enterprise Chronicles

2004

Established company and specialist in local anesthetic and antitussive APIs
2013

Put bismuth into production
2014

Merged with Xinghuo Pharma, introducing pediatric, respiratory, and cardiovascular drugs
2015

Commercial production of bio-enzymes & DHPG series
2016

Introducing trimebutine maleate API & FDFs
2022

Established SYPG and restructured business
2023

Newly-built Shuangyan bio-pharmaceutical industrial park
2024

Production for clavulanate & amoxicillin series

Put INJP into production

Potassium clavulanate with MCC & SiO₂ registered in India
2025

CEP for amoxicillin trihydrate powder/compacted & potassium clavulanate with MCC/SiO₂

News Media Center